Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Chronic Obstructive Lung Disease | Research

Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data

Authors: Jiahua Zou, Tao Sun, Xiaohui Song, Ye-Mao Liu, Fang Lei, Ming-Ming Chen, Ze Chen, Peng Zhang, Yan-Xiao Ji, Xiao-Jing Zhang, Zhi-Gang She, Jingjing Cai, Yunman Luo, Ping Wang, Hongliang Li

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

Global distributions and trends of the risk-attributable burdens of chronic obstructive pulmonary disease (COPD) have rarely been systematically explored. To guide the formulation of targeted and accurate strategies for the management of COPD, we analyzed COPD burdens attributable to known risk factors.

Methods

Using detailed COPD data from the Global Burden of Disease study 2019, we analyzed disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), and deaths attributable to each risk factor from 1990 to 2019. Additionally, we calculated estimated annual percentage changes (EAPCs) during the study period. The population attributable fraction (PAF) and summary exposure value (SEV) of each risk factor are also presented.

Results

From 1990 to 2019, the age-standardized DALY and death rates of COPD attributable to smoking and household air pollution, occupational particles, secondhand smoke, and low temperature presented consistently declining trends in almost all socio-demographic index (SDI) regions. However, the decline in YLD was not as dramatic as that of the death rate. In contrast, the COPD burden attributable to ambient particulate matter, ozone, and high temperature exposure showed undesirable increasing trends in the low- and low-middle-SDI regions. In addition, the age-standardized DALY and death rates attributable to each risk factor except household air pollution and low temperature were the highest in the low-middle-SDI region. In 2019, the COPD burden attributable to smoking ambient particulate matter, ozone, occupational particles, low and high temperature was obviously greater in males than in females. Meanwhile, the most important risk factors for female varied across regions (low- and low-middle-SDI regions: household air pollution; middle-SDI region: ambient particles; high-middle- and high-SDI region: smoking).

Conclusions

Increasing trends of COPD burden attributable to ambient particulate matter, ozone, and high temperature exposure in the low-middle- and low-SDI regions call for an urgent need to implement specific and effective measures. Moreover, considering the gender differences in COPD burdens attributable to some risk factors such as ambient particulate matter and ozone with similar SEV, further research on biological differences between sexes in COPD and relevant policy-making of disease prevention are required.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
2.
go back to reference GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96.CrossRef GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96.CrossRef
3.
go back to reference Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368:m234.CrossRef Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368:m234.CrossRef
4.
go back to reference GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
5.
go back to reference Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. The Lancet. 2016;388(10062):e19–23.CrossRef Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. The Lancet. 2016;388(10062):e19–23.CrossRef
6.
go back to reference Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.CrossRef Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.CrossRef
7.
go back to reference Michael J. GladePh.D. food, nutrition, physical activity and the prevention of cancer: a global perspective, world cancer research fund/American Institute for Cancer Research, American Institute for Cancer Research, Washington, D.C. (2007). Nutrition. 2007;24(4):393–8. Michael J. GladePh.D. food, nutrition, physical activity and the prevention of cancer: a global perspective, world cancer research fund/American Institute for Cancer Research, American Institute for Cancer Research, Washington, D.C. (2007). Nutrition. 2007;24(4):393–8.
9.
go back to reference Davis CH, MacKinnon DP, Schultz A, Sandler I. Cumulative risk and population attributable fraction in prevention. J Clin Child Adolesc Psychol. 2003;32(2):228–35.CrossRef Davis CH, MacKinnon DP, Schultz A, Sandler I. Cumulative risk and population attributable fraction in prevention. J Clin Child Adolesc Psychol. 2003;32(2):228–35.CrossRef
10.
go back to reference Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–83.CrossRef Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–83.CrossRef
11.
go back to reference Deng Y, Zhao P, Zhou L, et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study. J Hematol Oncol. 2020;13(1):98.CrossRef Deng Y, Zhao P, Zhou L, et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study. J Hematol Oncol. 2020;13(1):98.CrossRef
12.
go back to reference Wang H, Abbas KM, Abbasifard M, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1160–203.CrossRef Wang H, Abbas KM, Abbasifard M, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1160–203.CrossRef
13.
go back to reference Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–18.CrossRef Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–18.CrossRef
16.
go back to reference Ekström MP, Jogréus C, Ström KE. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS ONE. 2012;7(4):e35806.CrossRef Ekström MP, Jogréus C, Ström KE. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS ONE. 2012;7(4):e35806.CrossRef
17.
go back to reference Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.CrossRef Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.CrossRef
18.
go back to reference Perez TA, Castillo EG, Ancochea J, et al. Sex differences between women and men with COPD: a new analysis of the 3CIA study. Respir Med. 2020;171:106105.CrossRef Perez TA, Castillo EG, Ancochea J, et al. Sex differences between women and men with COPD: a new analysis of the 3CIA study. Respir Med. 2020;171:106105.CrossRef
19.
go back to reference Hong Y, Ji W, An S, Han S-S, Lee S-J, Kim WJ. Sex differences of COPD phenotypes in nonsmoking patients. Int J Chron Obstruct Pulmon Dis. 2016;11:1657–62.CrossRef Hong Y, Ji W, An S, Han S-S, Lee S-J, Kim WJ. Sex differences of COPD phenotypes in nonsmoking patients. Int J Chron Obstruct Pulmon Dis. 2016;11:1657–62.CrossRef
20.
go back to reference Lam KBH. Stable or fluctuating temperatures in winter: which is worse for your lungs? Thorax. 2018;73(10):902–3.CrossRef Lam KBH. Stable or fluctuating temperatures in winter: which is worse for your lungs? Thorax. 2018;73(10):902–3.CrossRef
21.
go back to reference Gasparrini A, Guo Y, Hashizume M, et al. Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet. 2015;386(9991):369–75.CrossRef Gasparrini A, Guo Y, Hashizume M, et al. Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet. 2015;386(9991):369–75.CrossRef
22.
go back to reference Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J. 1999;13(4):844–9.CrossRef Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J. 1999;13(4):844–9.CrossRef
23.
go back to reference Lin Z, Gu Y, Liu C, et al. Effects of ambient temperature on lung function in patients with chronic obstructive pulmonary disease: a time-series panel study. Sci Total Environ. 2018;619–620:360–5.CrossRef Lin Z, Gu Y, Liu C, et al. Effects of ambient temperature on lung function in patients with chronic obstructive pulmonary disease: a time-series panel study. Sci Total Environ. 2018;619–620:360–5.CrossRef
25.
go back to reference Hou W, Hu S, Li C, et al. Cigarette smoke induced lung barrier dysfunction, EMT, and tissue remodeling: a possible link between COPD and lung cancer. Biomed Res Int. 2019;2019:2025636.PubMedPubMedCentral Hou W, Hu S, Li C, et al. Cigarette smoke induced lung barrier dysfunction, EMT, and tissue remodeling: a possible link between COPD and lung cancer. Biomed Res Int. 2019;2019:2025636.PubMedPubMedCentral
26.
go back to reference Petecchia L, Sabatini F, Varesio L, et al. Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway. Chest. 2009;135(6):1502–12.CrossRef Petecchia L, Sabatini F, Varesio L, et al. Bronchial airway epithelial cell damage following exposure to cigarette smoke includes disassembly of tight junction components mediated by the extracellular signal-regulated kinase 1/2 pathway. Chest. 2009;135(6):1502–12.CrossRef
27.
go back to reference Nichter M. Smoking: what does culture have to do with it? Addiction. 2003;98(Suppl 1):139–45.CrossRef Nichter M. Smoking: what does culture have to do with it? Addiction. 2003;98(Suppl 1):139–45.CrossRef
28.
go back to reference Ho SY, Chen J, Leung LT, et al. Adolescent smoking in Hong Kong: prevalence, psychosocial correlates, and prevention. J Adolesc Health. 2019;64(6S):S19–27.CrossRef Ho SY, Chen J, Leung LT, et al. Adolescent smoking in Hong Kong: prevalence, psychosocial correlates, and prevention. J Adolesc Health. 2019;64(6S):S19–27.CrossRef
30.
go back to reference Naslund JA, Kim SJ, Aschbrenner KA, et al. Systematic review of social media interventions for smoking cessation. Addict Behav. 2017;73:81–93.CrossRef Naslund JA, Kim SJ, Aschbrenner KA, et al. Systematic review of social media interventions for smoking cessation. Addict Behav. 2017;73:81–93.CrossRef
31.
go back to reference Zahno M, Michaelowa K, Dasgupta P, Sachdeva I. Health awareness and the transition towards clean cooking fuels: evidence from Rajasthan. PLoS ONE. 2020;15(4):e0231931.CrossRef Zahno M, Michaelowa K, Dasgupta P, Sachdeva I. Health awareness and the transition towards clean cooking fuels: evidence from Rajasthan. PLoS ONE. 2020;15(4):e0231931.CrossRef
32.
go back to reference Balmes JR. Household air pollution from domestic combustion of solid fuels and health. J Allergy Clin Immunol. 2019;143(6):1979–87.CrossRef Balmes JR. Household air pollution from domestic combustion of solid fuels and health. J Allergy Clin Immunol. 2019;143(6):1979–87.CrossRef
33.
go back to reference Moore GF, Holliday JC, Moore LAR. Socioeconomic patterning in changes in child exposure to secondhand smoke after implementation of smoke-free legislation in Wales. Nicotine Tob Res. 2011;13(10):903–10.CrossRef Moore GF, Holliday JC, Moore LAR. Socioeconomic patterning in changes in child exposure to secondhand smoke after implementation of smoke-free legislation in Wales. Nicotine Tob Res. 2011;13(10):903–10.CrossRef
34.
go back to reference Rigotti NA, Pashos CL. No-smoking laws in the United States. An analysis of state and city actions to limit smoking in public places and workplaces. JAMA. 1991;266(22):3162–7.CrossRef Rigotti NA, Pashos CL. No-smoking laws in the United States. An analysis of state and city actions to limit smoking in public places and workplaces. JAMA. 1991;266(22):3162–7.CrossRef
35.
go back to reference Ruprecht A, Boffi R, Mazza R, Rossetti E, De Marco C, Invernizzi G. A comparison between indoor air quality before and after the implementation of the smoking ban in public places in Italy. Epidemiol Prev. 2006;30(6):334–7.PubMed Ruprecht A, Boffi R, Mazza R, Rossetti E, De Marco C, Invernizzi G. A comparison between indoor air quality before and after the implementation of the smoking ban in public places in Italy. Epidemiol Prev. 2006;30(6):334–7.PubMed
37.
go back to reference Collaborators GBDCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706.CrossRef Collaborators GBDCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706.CrossRef
38.
go back to reference Miller MR, Levy ML. Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ. 2015;351:h3021.CrossRef Miller MR, Levy ML. Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ. 2015;351:h3021.CrossRef
Metadata
Title
Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data
Authors
Jiahua Zou
Tao Sun
Xiaohui Song
Ye-Mao Liu
Fang Lei
Ming-Ming Chen
Ze Chen
Peng Zhang
Yan-Xiao Ji
Xiao-Jing Zhang
Zhi-Gang She
Jingjing Cai
Yunman Luo
Ping Wang
Hongliang Li
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02011-y

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine